Skip to main content

Advertisement

SpringerLink
Log in

Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease

  • Respiratory Infections (F Arnold, Section Editor)
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Patients with COPD are at increased risk for community-acquired pneumonia (CAP). COPD has been reported as a comorbidity in at least one third of the hospitalized patients with CAP. There is a controversy that the presence of concomitant COPD and CAP is associated with a greater risk of death when compared to either condition alone. Risk factors, clinical and immunological characteristics, microbiological etiology, as well as prognosis and treatment of COPD patients with CAP are reviewed in this article.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Global initiative for chronic obstructive lung disease global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Updated 2014. [Accessed June 11, 2014]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jun11.pdf.

  2. Ishiguro T, Takayanagi N, Yamaguchi S, et al. Etiology and factors contributing to the severity and mortality of community-acquired pneumonia. Intern Med. 2013;52:317–24.

    Article  PubMed  Google Scholar 

  3. Müllerova H, Chigbo C, Hagan GW, et al. The natural history of community-acquired pneumonia in COPD patients: a population database analysis. Respir Med. 2012;106:1124–33. This large COPD cohort evaluates the characteristics of COPD patients who are at greatest risk for pneumonia as well as pneumonia incidence in this population.

    Article  PubMed  Google Scholar 

  4. Merino-Sanchez M, Alfageme-Michavila I, Reyes-Nunez N, et al. Prognosis in patients with pneumonia and chronic obstructive pulmonary disease. Arch Bronconeumol. 2005;41:607–11.

    Article  CAS  PubMed  Google Scholar 

  5. Ryan M, Suaya JA, Chapman JD, et al. Incidence and cost of pneumonia in older adults with COPD in the United States. PLoS One. 2013;8(10):e75887.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Boersma WG, Sportel JH, Löwenberg A, et al. High prevalence of obstructive airways disease in hospitalized patients with community-acquired pneumonia: comparison of four etiologies. Clin Pulm Med. 2005;12:291–6.

    Article  Google Scholar 

  7. Crim C, Calverley PMA, Anderson JA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study result. Eur Respir J. 2009;34:641–7.

    Article  CAS  PubMed  Google Scholar 

  8. Mannino DM, Davis KJ, Kiri VA. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort. Respir Med. 2009;103:224–9.

    Article  PubMed  Google Scholar 

  9. Myint PK, Lowe D, Stone RA, et al. U.K. National COPD Resources and Outcomes Project 2008: patients with chronic obstructive pulmonary disease exacerbations who present with radiological pneumonia have worse outcome compared to those with non-pneumonic chronic obstructive pulmonary disease exacerbations. Respiration. 2011;82:320–7.

    Article  PubMed  Google Scholar 

  10. Lin S-H, Ji B-C, Shih Y-M, et al. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients. Int J Tuberc Lung Dis. 2013;17:1638–44.

    Article  PubMed  Google Scholar 

  11. Disantostefano RL, Li H, Hinds D, et al. Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis. Int J Chron Obstruct Pulmon Dis. 2014;9:457–68.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Liapikou A, Polverino E, Ewig S, et al. Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients. Eur Respir J. 2012;39:855–61.

    Article  CAS  PubMed  Google Scholar 

  13. Rello J, Rodriguez A, Torres A, et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J. 2006;27:1210–6.

    Article  CAS  PubMed  Google Scholar 

  14. Restrepo MI, Mortensen EM, Pugh JA, et al. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J. 2006;28:346–51.

    Article  CAS  PubMed  Google Scholar 

  15. Molinos L, Clemente MG, Miranda B, et al. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect. 2009;58:417–24.

    Article  CAS  PubMed  Google Scholar 

  16. Cilli A, Erdem H, Karakurt Z, et al. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: risk factors for mortality. J Crit Care. 2013;28:975–9.

    Article  PubMed  Google Scholar 

  17. Pifarre R, Falguera M, Vicente-de-Vera C, et al. Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Respir Med. 2007;101:2139–44.

    Article  PubMed  Google Scholar 

  18. Ko FW, Ip M, Chan PK, et al. A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia. Respir Med. 2008;102:1109–16.

    Article  PubMed  Google Scholar 

  19. Torres A, Dorca J, Zalacain R, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;154:1456–61.

    Article  CAS  PubMed  Google Scholar 

  20. Snijders D, Van Der Eerden M, De Graaff C, et al. The influence of COPD on mortality and severity scoring in community-acquired pneumonia. Respiration. 2010;79:46–53.

    Article  PubMed  Google Scholar 

  21. Lieberman D, Lieberman D, Gelfer Y, et al. Pneumonic vs nonpneumonic acute exacerbations of COPD. Chest. 2002;122:1264–70.

    Article  PubMed  Google Scholar 

  22. Huerta A, Crisafulli E, Menendez R, et al. Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics. Chest. 2013;144:1134–42.

    Article  CAS  PubMed  Google Scholar 

  23. Kew KM, Seniukovich A. Inhaled steroids and the risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;3. This large review shows the close association between inhaled corticosteroid use and the increased risk of serious adverse pneumonia events.

  24. Jen R, Rennard SI, Sin DD. Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2012;7:587–95.

    PubMed Central  CAS  PubMed  Google Scholar 

  25. Garcha DS, Thurston SJ, Patel AR, et al. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax. 2012;67:1075–80.

    Article  PubMed  Google Scholar 

  26. Crisafulli E, Menendez R, Huerta A, et al. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD. Chest. 2013;143:1009–17.

    Article  CAS  PubMed  Google Scholar 

  27. Ferrer M, Torres A, Martinez R, et al. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study. Respirology. 2014;19(6):929–35.

    Article  PubMed  Google Scholar 

  28. Murphy TF, Brauer AL, Eschberger K, et al. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:853–60.

    Article  CAS  PubMed  Google Scholar 

  29. Sethi S. Infection as a comorbidity of COPD. Eur Respir J. 2010;35:1209–15.

    Article  CAS  PubMed  Google Scholar 

  30. Rangelov K, Sethi S. Role of infections. Clin Chest Med. 2014;35:87–100.

    Article  PubMed  Google Scholar 

  31. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:27–72.

    Article  Google Scholar 

  32. Calbo E, Valdés E, Ochoa de Echagüen A, et al. Bacteraemic pneumococcal pneumonia in COPD patients: better outcomes than expected. Eur J Clin Microbiol Infect Dis. 2009;28:971–6.

    Article  CAS  PubMed  Google Scholar 

  33. Marrie TJ. Bacteraemic pneumococcal pneumonia: a continuously evolving disease. J Infect. 1992;24:247–55.

    Article  CAS  PubMed  Google Scholar 

  34. Pérez-Trallero E, Marimón JM, Larruskain J, et al. Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae isolates from elderly patients with pneumonia and acute exacerbation of chronic obstructive pulmonary disease. Antimicrob Agents Chemother. 2011;55:2729–34.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Domenech A, Ardanuy C, Calatayud L, et al. Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute exacerbations in patients with chronic obstructive pulmonary disease. J Antimicrob Chemother. 2011;66:487–93.

    Article  CAS  PubMed  Google Scholar 

  36. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–50.

    Article  CAS  PubMed  Google Scholar 

  37. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Loke YK, Kwok CS, Wong JM, et al. Chronic obstructive pulmonary disease and mortality from pneumonia: meta analysis. Int J Clin Pract. 2013;67:477–87.

    Article  CAS  PubMed  Google Scholar 

  39. Garcia Vidal C, Calbo E, Pascual V, et al. Effects of systemic steroids in patients with severe community-acquired pneumonia. Eur Respir J. 2007;30:951–6.

    Article  CAS  PubMed  Google Scholar 

  40. Andreassen SL, Liaaen ED, Stenfors N, et al. Impact of pneumonia on hospitalizations due to acute exacerbations of COPD. Clin Respir J. 2014;8:93–9.

    Article  CAS  PubMed  Google Scholar 

  41. Sibila O, Mortensen EM, Anzueto A, et al. Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia. Eur Respir J. 2014;43:36–42. This study examines the impact of prior cardiovascular disease in short-and long-term mortality in COPD patients hospitalised with pneumonia.

    Article  PubMed Central  PubMed  Google Scholar 

  42. Chen D, Restrepo MI, Fine MJ, et al. Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia. Am J Respir Crit Care Med. 2011;184:312–6.

    Article  PubMed Central  PubMed  Google Scholar 

  43. de Malo MR, Mortensen EM, Restrepo MI, et al. Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalized with pneumonia. Eur Respir J. 2010;36:751–7.

    Article  Google Scholar 

  44. Singanayagam A, Chalmers JD, Akram AR, et al. Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia. Eur Respir J. 2011;38:36–41.

    Article  CAS  PubMed  Google Scholar 

  45. Almirall J, Bolibar I, Serra-Prat M, et al. Relationship between the use of inhaled steroids for chronic respiratory diseases and early outcomes in community-acquired pneumonia. PLoS One. 2013;8(9):e73271.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  46. Sibila O, Laserna E, Mortensen EM, et al. Effects of inhaled corticosteroids on pneumonia severity and antimicrobial resistance. Respir Care. 2013;58:1489–94.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Friedland IR, McCarroll KA, DiNubile MJ, Woods GL. Ertapenem as initial antimicrobial monotherapy for patients with chronic obstructive pulmonary disease hospitalized with typical community-acquired pneumonia. Pulm Pharmacol Ther. 2004;17(4):199–203.

    Article  CAS  PubMed  Google Scholar 

  48. Lim WS, Baudouin SV, George RC, Pneumonia Guidelines Committee of the BTS Standards of Care Committee, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64 Suppl 3:iii1–55.

    Article  PubMed  Google Scholar 

  49. Menéndez R, Torres A, Aspa J, Sociedad Española de Neumología y Cirugía Torácica, et al. Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR). Arch Bronconeumol. 2010;46:543–58.

    Article  PubMed  Google Scholar 

  50. Woodhead M, Blasi F, Ewig S, Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases, et al. Guidelines for the management of adult lower respiratory tract infections—full version. Clin Microbiol Infect. 2011;17 Suppl 6:E1–59.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Aykut Cill has no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Author information

Authors and Affiliations

  1. Department of Pulmonary Diseases, University of Akdeniz, Dumlupinar Bulvari, Kampus, 07059, Antalya, Turkey

    Aykut Cilli

Authors
  1. Aykut Cilli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aykut Cilli.

Additional information

This article is part of the Topical Collection on Respiratory Infections

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cilli, A. Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease. Curr Infect Dis Rep 17, 444 (2015). https://doi.org/10.1007/s11908-014-0444-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11908-014-0444-7

Keywords

Search

Navigation